Hero
Our Approach
Simulations capture patient biology where experiments fail
Platform
Engineering a way to understand biology
Pipeline
A single platform to rationalize the entire R&D process
Meet Us
Building deep tech for deep biology
Notification
Join our mission
Read about us
Hero
Our Approach
Platform
Pipeline
Meet Us
Notification
Join our mission
Read about us
A Hungarian company aiming to reform oncology R&D through a simulated cell model received ~HUF 8 Bn through venture funding
23 November 2022
back
16 May 2024
Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development
read more
01 April 2024
Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy
read more
All rights reserved ©2024 Turbine Ltd. |
Privacy Policy
|
Created by Art&Board Studio
close
Read our fresh publication on npj - systems biology and applications!
Network-driven cancer cell avatars for combination discovery and biomarker identification for DNA damage response inhibitors
Read our poster for EACR 2024!
The Simulated Cell™ identifies LIG4 as a novel target in PARPi resistance via the modulation of NHEJ deficiency